Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia (CLL) cells from apoptosis: Role for LPA as a survival factor in CLL.

被引：0
|
作者：
Gibson, SB [1 ]
Hu, XJ [1 ]
Haney, N [1 ]
Kabore, AF [1 ]
Johnston, JB [1 ]
机构：
[1] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4788.4788
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4788
引用
收藏
页码：280B / 280B
页数：1
相关论文
共 50 条
  • [1] The vascular endothelial growth factor (VEGF) autocrine survival signaling pathway in chronic lymphocytic leukemia (CLL) is regulated by lysophosphatidic acid (LPA).
    Hu, Xiaojie
    Sun, Jinmie
    Johnston, James B.
    Gibson, Spencer B.
    BLOOD, 2006, 108 (11) : 795A - 795A
  • [2] Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB
    Hu, XJ
    Haney, N
    Kropp, D
    Kabore, AF
    Johnston, JB
    Gibson, SB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) : 9498 - 9508
  • [3] Lysophosphatidic acid protects chronic lymphocytic leukemia cells against apoptosis.
    Johnston, JB
    Haney, N
    Kabore, A
    Hu, XJ
    Gibson, SB
    BLOOD, 2003, 102 (11) : 352B - 352B
  • [4] The leukotriene receptor CysLT1 is involved in migration and survival of chronic lymphocytic leukemia (CLL) cells:: Potential role of CysLT1 antagonists in the treatment of CLL.
    Boehmler, AM
    Seitz, G
    Wiesner, T
    Kanz, L
    Möhle, R
    BLOOD, 2003, 102 (11) : 439A - 439A
  • [5] Apoptosis and Proliferation Synergistically Determine Overall Survival in Chronic Lymphocytic Leukemia (CLL)
    Del Poeta, Giovanni
    Dal Bo, Michele
    Buccisano, Francesco
    Pozzo, Federico
    Del Principe, Maria Ilaria
    Bulian, Pietro
    Rossi, Davide
    Venditti, Adriano
    de Fabritiis, Paolo
    Gaidano, Gianluca
    Amadori, Sergio
    Gattei, Valter
    BLOOD, 2015, 126 (23)
  • [6] STAT3-induced GM-CSFRα Protects Chronic Lymphocytic Leukemia (CLL) Cells From Apoptosis
    Rozovski, Uri
    Li, Ping
    Harris, David
    Liu, Zhiming
    Ferrajoli, Alessandra
    Bueso-Ramos, Carlos
    Hazan-Halevy, Inbal
    Grgurevic, Srdana
    Wierda, William
    Burger, Jan
    O'Brien, Susan
    Fader, Stefan
    Keating, Michael
    Estrov, Zeev
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S134 - S134
  • [7] The role of the VLA-4 integrin in adhesion and survival of chronic lymphocytic leukemia (CLL) cells
    Sahakyan, K.
    Hofbauer, S.
    Brachtl, G.
    Girbl, T.
    Henschler, R.
    Greil, R.
    Hartmann, T. N.
    ONKOLOGIE, 2010, 33 : 201 - 201
  • [8] Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
    Nistico, Nancy
    Maisano, Domenico
    Iaccino, Enrico
    Vecchio, Eleonora
    Fiume, Giuseppe
    Rotundo, Salvatore
    Quinto, Ileana
    Mimmi, Selena
    PHARMACEUTICALS, 2020, 13 (09) : 1 - 14
  • [9] Resistance of chronic lymphocytic leukemia cells in apoptosis: key role of stromal cells in maintaining the redox potential of CLL cells
    Zhang, Wan
    Feng, Li
    Pelicano, Helene
    Huang, Peng
    M S-MEDECINE SCIENCES, 2013, 29 (01): : 36 - 38
  • [10] The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells
    Kardava, Lela
    Yang, Qi
    Leger, Anthony St.
    Foon, Kenneth A.
    Lentzsch, Suzanne
    Vallejo, Abbe N.
    Milcarek, Christine
    Borghesi, Lisa
    INTERNATIONAL IMMUNOLOGY, 2011, 23 (06) : 375 - 384
12345